Lead Product(s) : Cidofovir
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Intravesical Cidofovir for Hemorrhagic Cystitis
Details : Cidofovir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 22, 2013
Lead Product(s) : Cidofovir
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Gilead Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
